Individualized Immunosuppression in Transplant Patients: Potential Role of Pharmacogenetics

Pharmacogenomics and Personalized Medicine - New Zealand
doi 10.2147/pgpm.s21743
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Handling of Fungal Infections in Patients With Chronic Immunosuppression Post Renal Transplant

2011English

Pharmacogenetics and Pharmacogenomics: A Bridge to Individualized Cancer Therapy

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2013English

Everolimus-Based Immunosuppression in Liver Transplant Recipients

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Methimazole and Generation of Oxygen Radicals by Monocytes: Potential Role in Immunosuppression.

BMJ
1984English

Immunosuppression in Pediatric Liver Transplant Recipients: Unique Aspects

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Pharmacogenetics of Intravenous and Oral Busulfan in Hematopoietic Cell Transplant Recipients

Journal of Clinical Pharmacology
Pharmacology
2011English

Potential Role of UGT Pharmacogenetics in Cancer Treatment and Prevention: Focus on Tamoxifen and Aromatase Inhibitors

Drug Metabolism Reviews
ToxicologyPharmaceuticsPharmacology
2009English

Integrin Antagonists for Transplant Immunosuppression: Panacea or Peril?

Immunotherapy
OncologyAllergyImmunology
2011English

Potential of Targeting TGF-β for Organ Transplant Patients

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy